These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 20511314)

  • 1. Community pharmacy. Costs of minor ailment schemes.
    Sewak NS
    BMJ; 2010 May; 340():c2865. PubMed ID: 20511314
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost analysis of a community pharmacy 'minor ailment scheme' across three primary care trusts in the North East of England.
    Baqir W; Learoyd T; Sim A; Todd A
    J Public Health (Oxf); 2011 Dec; 33(4):551-5. PubMed ID: 21339201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of pharmacist intervention in general practice: the effect on prescribing costs.
    Rodgers S; Avery AJ; Meechan D; Briant S; Geraghty M; Doran K; Whynes DK
    Br J Gen Pract; 1999 Sep; 49(446):717-20. PubMed ID: 10756613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic feasibility of pharmacy patient medication profiles.
    Zelnio RN; Feldman R; Gagnon JP
    Inquiry; 1978 Jun; 15(2):181-8. PubMed ID: 149765
    [No Abstract]   [Full Text] [Related]  

  • 6. Choices in prescription-drug benefit programs: mail versus community pharmacy services.
    Kirking DM; Ascione FJ; Richards JW
    Milbank Q; 1990; 68(1):29-51. PubMed ID: 2215427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacy. Appalling bias.
    Martin JR
    BMJ; 2010 May; 340():c2880. PubMed ID: 20511316
    [No Abstract]   [Full Text] [Related]  

  • 8. Medicines: effectiveness or cost.
    Blockman M
    S Afr Med J; 2009 Jan; 99(1):11. PubMed ID: 19374077
    [No Abstract]   [Full Text] [Related]  

  • 9. Model for cost-benefit analysis of clinical pharmacy in family practice.
    Chrischilles EA; Helling DK; Rowland CR
    Am J Hosp Pharm; 1982 Jun; 39(6):992-8. PubMed ID: 6808837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.
    Paudyal V; Hansford D; Scott Cunningham IT; Stewart D
    Int J Pharm Pract; 2010 Aug; 18(4):194-201. PubMed ID: 20636670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effective shopping for prescription drugs.
    Duvall LA; Campbell TA
    J S C Med Assoc; 1988 Feb; 84(2):78-81. PubMed ID: 3162287
    [No Abstract]   [Full Text] [Related]  

  • 13. Community pharmacy treatment of minor ailments in refugees.
    Parmentier H; Golding S; Ashworth M; Rowlands G
    J Clin Pharm Ther; 2004 Oct; 29(5):465-9. PubMed ID: 15482391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacy: moving from dispensing to diagnosis and treatment.
    Richardson E; Pollock AM
    BMJ; 2010 May; 340():c2298. PubMed ID: 20460333
    [No Abstract]   [Full Text] [Related]  

  • 15. Community pharmacy.
    Ford S
    Br J Gen Pract; 1994 Nov; 44(388):534-5. PubMed ID: 7748658
    [No Abstract]   [Full Text] [Related]  

  • 16. [NPT (near patient test) in the pharmacy: document and practice guidelines 2008].
    Stuard S; Cesarone MR; Belcaro G; Ledda A; Cornelli U; Di Renzo A; Grossi MG; Pellegrini L; Gizzi G; Vinciguerra G; Dugall M; Corsi M; Ippolito E; Di Palma T; Zulli C; Del Boccio G
    Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):11-20. PubMed ID: 19597405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
    Thavorn K; Chaiyakunapruk N
    Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
    Boyd KA; Briggs AH
    Addiction; 2009 Feb; 104(2):317-25. PubMed ID: 19149829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
    Bauld L; Boyd KA; Briggs AH; Chesterman J; Ferguson J; Judge K; Hiscock R
    Nicotine Tob Res; 2011 Feb; 13(2):135-45. PubMed ID: 21196451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How community drug sales schemes may succeed.
    Foster S; Drager N
    World Health Forum; 1988; 9(2):200-6. PubMed ID: 3254213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.